Posted on 1/7/19
Berkshire Hathaway Specialty Insurance Names Alfred Barth Senior Claims Adjuster in Germany
BOSTON--(BUSINESS WIRE)--Berkshire Hathaway Specialty Insurance (BHSI) has expanded its team in Europe with the appointment of Alfred Barth as Senior Claims Adjuster in Germany.“Alfred brings extensive . . .
Posted on 1/7/19
TA Associates Announces 2019 Global Staff Promotions
BOSTON--(BUSINESS WIRE)--TA Associates, a leading global growth private equity firm, today announced promotions earned by 10 staff members in the firm’s Boston, Menlo Park, Hong Kong . . .
Posted on 1/4/19
Kim Crowley Joins Korn Ferry as Senior Client Partner
LOS ANGELES--(BUSINESS WIRE)--Korn Ferry (NYSE:KFY) today announced that Kim Crowley has joined the firm as senior client partner and global account leader in the Life Sciences . . .
Posted on 1/4/19
TILT Holdings Appoints David Caloia CFO
TILT Holdings Inc. (CSE: TILT) (OTC: SVVTF), a diversified, multinational infrastructure and technology cannabis company, today announced the appointment of David Caloia
Posted on 1/4/19
Archway Health Bolsters Leadership Team with Industry Veterans
WATERTOWN, Mass.--(BUSINESS WIRE)--Archway Health, an innovator with healthcare organizations and self-insured employers in risk-based payment programs, today announced the addition of three new members of the . . .
Posted on 1/4/19
Harbour BioMed Appoints Atul Deshpande, Ph.D. MBA, Chief Strategy Officer and Head of U.S. Operations
Harbour BioMed announced the appointment of Atul Deshpande, Ph.D. MBA, as Chief Strategy Officer and
Posted on 1/4/19
Lando & Anastasi Announces Four Attorneys Elevated to Partnership
Lando & Anastasi, LLP (L&A) is proud to announce that Gregory K. Gerstenzang, Nathan T. Harris, Hannah R. Koyfman, Ph.D., and David M. Roccio have been . . .
Posted on 1/4/19
Hooker & Holcombe Appoints Pam Minish as Managing Director
Hooker & Holcombe, a regional leader in employer-based actuarial, investment advisory and retirement plan consulting, is excited to announce expansion within its Investment Advisory Group. The . . .
Posted on 1/4/19
Brammer Bolsters Leadership Team and Announces Chief Quality Officer
Brammer Bio, a best-in-class viral vector contract development and manufacturing organization (CDMO) for companies developing gene-modified cell therapies and in vivo gene therapies, announces recent leadership . . .
Posted on 1/4/19
Silversmith Capital Partners Promotes Sri Rao to General Partner
BOSTON--(BUSINESS WIRE)--Silversmith Capital Partners today announced the promotion of Sri Rao to General Partner. Since joining Silversmith in 2015, Mr. Rao has played a key role . . .
Posted on 1/4/19
Commonwealth Financial Network Congratulates Honorees on the NAPA Top Retirement Plan Advisors Under 40 List
WALTHAM, Mass.--(BUSINESS WIRE)--Commonwealth Financial Network®, the nation’s largest privately held Registered Investment Adviser–independent broker/dealer, congratulates three affiliated advisors on being named to the National Association of . . .
Posted on 1/4/19
GI Dynamics Appoints Stephen Linhares VP of Clinical and Regulatory Affairs
BOSTON & SYDNEY--(BUSINESS WIRE)--GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2 diabetes and obesity, is pleased to . . .
Posted on 1/4/19
Unitil SVP, CFO and Treasurer Mark H. Collin to Retire
HAMPTON, N.H., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE:UTL) (www.unitil.com) today announced the planned retirement of Mark H. Collin, Senior Vice President, Chief Financial Officer . . .
Posted on 1/4/19
ImmusanT Appoints Thomas A. Shea as CFO
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- ImmusanT, Inc., a clinical-stage company leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies . . .
Posted on 1/4/19
SQZ Biotech Appoints Oliver Rosen CMO
WATERTOWN, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, today announced the appointment . . .
Posted on 1/3/19
Hamilton, Brook, Smith & Reynolds, P.C. Elects Alexander Adam, Ph.D. and Christopher Albert as Principals
Hamilton, Brook, Smith & Reynolds, P.C. is pleased to announce that Alex Adam, Ph.D. and Chris Albert have been elected principals of the firm.Alex has a Ph.D. . . .
Posted on 1/3/19
Aldeyra Therapeutics Announces Promotion of David McMullin to Position of Chief Commercial Officer
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced . . .
Posted on 1/3/19
TARIS Appoints Tony Kingsley as President and Chief Executive Officer
TARIS Bio, a biopharmaceutical company developing transformational therapies to treat people with debilitating urological disorders, announced today that Tony Kingsley has joined the company as president . . .
Posted on 1/3/19
Group1001 Appoints Linda Wang as Head of Corporate Planning
Group1001 announced today the hiring of Linda Wang as Head of Corporate Planning for the organization. Reporting directly to CEO and President, Dan Towriss, Wang will . . .
Posted on 1/3/19
Flare Capital Partners Promotes Dan Gebremedhin, MD, to Partner
Flare Capital Partners, a market leading healthcare technology venture capital firm, today announced the promotion of Dan Gebremedhin to Partner.
Posted on 1/3/19
Rallybio Further Strengthens Leadership Team with Addition of Steven Ryder, MD, FACP
FARMINGTON, Conn.--(BUSINESS WIRE)--Rallybio LLC, a development-stage biotechnology company, today announced that it continues to expand its drug acquisition and development capabilities with the addition of Steven . . .
Posted on 1/3/19
Fulcrum Therapeutics Appoints Bryan Stuart as Chief Operating Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, today announced the . . .
Posted on 1/3/19
Unum Therapeutics Announces Transition of Chief Financial Officer
CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of novel cellular immunotherapies, today . . .
Posted on 1/2/19
W. R. Berkley Corp. Announces Senior Executive Appointments
GREENWICH, Conn.--(BUSINESS WIRE)--W. R. Berkley Corporation (NYSE:WRB) today announced the appointment of Philip S. Welt as executive vice president and general counsel. In addition, Joseph L. . . .
Posted on 1/2/19
AdminaHealth Appoints Neil Kaufman as CTO
AdminaHealth LLC, a leading provider of technology and financial solutions for the insurance marketplace, today announced it has named Neil Kaufman to serve as its CTO.

